Skip to main content
Fig. 2 | Cancer Imaging

Fig. 2

From: Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma

Fig. 2

A 41-year male treated by DEB-TACE for advanced primary HCC. A-B CT revealed a large tumor of 133.2 mm in right liver one month after conventional TACE. C The tumor artery was superselectively incubated and embolized by 300-500 μm raltitrexed-loaded beads. D CT revealed a shrunk tumor 1.3 months after first DEB-TACE. E A second DEB-TACE was performed with 300-500 μm raltitrexed-loaded beads. F The tumor was found to shrink after 5.1 months' follow-up, but died of disease progression 7.5 months later

Back to article page